B-Lymphoid and myeloid lineages biphenotypic acute leukemia with t(8;21)(q22;q22)

International Journal of Hematology

Volumn 87, Issue 2, 2008, Pages 132-136

  He, Guangsheng ^a   Wu, Depei ^a   Sun, Aining ^a   Xue, Yongquan ^a   Jin, Zhengming ^a   Qiu, Huiying ^a   Tang, Xiaowen ^a   Miao, Miao ^a   Fu, Zhengzheng ^a   Ma, Xiao ^a   Wang, Xiuli ^a   Chen, Zixin ^a   Ruan, Changgeng ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Acute; AML1 ETO; Biphenotypic; Leukemia; t(8; 21)(q22; q22)

Indexed keywords

CD33 ANTIGEN; CD34 ANTIBODY; CYTARABINE; DAUNORUBICIN; HLA DR ANTIGEN; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION Y; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; HUMAN; IMMUNOPHENOTYPING; MALE; PHENOTYPE; REMISSION; SCORING SYSTEM; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD79; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSLOCATION, GENETIC;

EID: 42049097015     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0029-z     Document Type: Article

References (17)

1. Ferrara F, Vecchio LD. Acute Myeloid Leukemia with t(8;21)(q22;q22) /AML1/ETO: A distinct biological and clinical enity. Haematologica. 2002;87:306-19.
2. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB; European Group for the Immunological Characterization of Leukemia (EGIL). Proposals for the immunological classification of acute leukemias. Leukemia 1995;9:1783-6.
3. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med. 1985;103:620-5.
4. Andrieu V, Radford-Weiss I, Troussard X, et al. Molecular detection of t(8,21)/AML1/ETO in AMLM1/M2: correlation with cytogenetics, morphology and immunophenotype. Br J Haematol. 1996;92:855-65.
5. Brunning RD, Matutes E, Borowitz MJ, et al Acute leukemia of ambiguous lineage. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, (eds). Pathology and genetics of tumors of the haematopoietic and lympholoid tissue. Lyon: IARC Press; 2001:106-7.
6. Legrand O, Perrot J-Y, Simonin G, et al. Adult biphenotypic acute leukemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol. 1998:100:147-55.
7. Carbonell F, Swansbury J, Min T, et al. Cytogenetic findings in acute biphenotypic leukemia. Leukemia. 1996;10:1283-7.
8. Kozlov I, Beason K, Yu C, Hughson M. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity. Cancer Genet Cytogenet. 2005;163:62-7.
9. Kuchenbauer F, Feuring-Buske M, Buske C. AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemia. Cell cycle. 2005;4:1716-8.
10. Miyamoto T, Weissman IL, Akashi K. AML/ETO1-expressing non-leukemia stem cells in acute myelogenous leukemia with t(8;21) chromosomal translocation. Proc Natl Acad Sci USA. 2000;97:7521-6.
11. Libermann TA, Pan Z, Akbarali Y, et al. AML1 (CBFalpha2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter. J Biol Chem. 1999;274:24671-6.
12. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999;401:556-62.
13. Kozmik Z, Wang S, Dorfler P, Adams B, Busslinger M. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol. 1992;12:2662-72.
14. Nutt SL, Morrison AM, Dorfler P, Rolink A, Busslinger M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 1998;17:2319-33.
15. Fitzsimmons D, Hodsdon W, Wheat W, Maira SM, Wasylyk B, Hagman J. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 1996;10:2198-211.
16. Zwollo P, Desiderio S. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein. J Biol Chem. 1994;269:15310-7.
17. Kishi H, Wei XC, Jin ZX, et al. Lineage-specific regulation of the murine RAG-2 promoter: GATA-3 in T cells and Pax-5 in B cells. Blood. 2000;95:3845-52.